Magenta Therapeutics also develops a pipeline of small molecules; biologics, including antibody drug conjugates; and a cell therapy, which transplant options for many more patients with autoimmune diseases, blood cancers and genetic diseases. Its C100 program targets HSCs, immune cells and disease-causing cells. The C200 program targets HSCs and disease-causing cells, and the C300 program targets only immune cells.
Magenta Therapeutics also has a research and clinical collaboration agreement with AVROBIO to evaluate targeted antibody-drug conjugates as a conditioning regimen for lentiviral gene therapies.
The towering $15 Goldman Sachs price target compares to the even higher $18.50 consensus target. Shares traded mostly below $7 last week. Hitting the Goldman Sachs target would be a massive 120% gain.
NextTier Oilfield Solutions
This oilfield services company is less well known to investors but has massive upside to the Goldman target. NextTier Oilfield Solutions (NYSE: NEX) is the third largest provider of U.S. land completion services, including 2.2 million hydraulic horsepower and other services.
This industry-leading company has a diverse set of well completion and production services across the most active and demanding basins. Its integrated solutions approach delivers efficiency, and the firm’s ongoing commitment to innovation helps its customers better address what is coming next.
NexTier is differentiated through four points of distinction, including safety performance, efficiency, partnership and innovation, and it may be one of the most compelling energy stocks today.
Goldman Sachs has set a $5 price target. The consensus target is $3.75, and shares slipped below $2 last month and have yet to recover. Trading to the Goldman Sachs target would be an incredible 170% gain.
This is an incredible energy play for investors that may be a touch more conservative. TechnipFMC PLC (NYSE: FTI) engages in the oil and gas projects, technologies and systems and services businesses. It operates through three segments
The Subsea segment manufactures and designs products and systems; performs engineering, procurement and project management; and provides services used by oil and gas companies involved in deepwater exploration and production of crude oil and natural gas.
The Onshore/Offshore segment designs and builds onshore facilities related to the production, treatment and transportation of oil and gas, and it designs, manufactures and installs fixed and floating platforms for the production and processing of oil and gas reserves.
The Surface Technologies segment designs and manufactures systems, as well as provides services used by oil and gas companies involved in the land and shallow water exploration and production of crude oil and natural gas. This segment also designs, manufactures and supplies technologically advanced high-pressure valves and fittings for oilfield service companies, and it provides flowback and well-testing services for exploration and production companies.
Goldman Sachs has a $12.50 price objective on TechnipFMC stock. The consensus target price is $11.75, and shares traded above $6 apiece recently. Hitting that Goldman Sachs target would be a strong 100% gain.
These five companies have all been sent to the single-digit penalty box. Some of them may have a difficult road back to prosperity, but given what we have seen in the past, and the massive liquidity being provided by Washington, D.C., the odds are good that each survives this downturn and could head much higher in the last quarter of the year and especially in 2021.